Biomedical Engineering Reference
In-Depth Information
291. Loe DW, Almquist KC, Cole SP, Deeley RG. 1996. ATP-dependent 17 beta-estradiol
17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by
cholestatic steroids. J Biol Chem 271: 9683-9689.
292. Loe DW, Almquist KC, Deeley RG, Cole SP. 1996. Multidrug resistance protein (MRP)-
mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles:
demonstration of glutathione-dependent vincristine transport. J Biol Chem 271: 9675-
9682.
293. Mao Q, Deeley RG, Cole SP. 2000. Functional reconstitution of substrate transport by
purified multidrug resistance protein MRP1 (ABCC1) in phospholipid vesicles. J Biol
Chem 275: 34166-34172.
294. Mao Q, Qiu W, Weigl KE, Lander PA, Tabas LB, Shepard RL, Dantzig AH, Deeley
RG, Cole SP. 2002. GSH-dependent photolabeling of multidrug resistance protein MRP1
(ABCC1) by [125I]LY475776. Evidence of a major binding site in the COOH-proximal
membrane spanning domain. J Biol Chem 277: 28690-28699.
295. Jedlitschky G, Keppler D. 2002. Transport of leukotriene C4 and structurally related
conjugates. Vitam Horm 64: 153-184.
296. Haimeur A, Conseil G, Deeley RG, Cole SP. 2004. The MRP-related and BCRP/ABCG2
multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug
Metab 5: 21-53.
297. Loe DW, Deeley RG, Cole SP. 1998. Characterization of vincristine transport by the
M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced
glutathione. Cancer Res 58: 5130-5136.
298. Salerno M, Garnier-Suillerot A. 2001. Kinetics of glutathione and daunorubicin efflux
from multidrug resistance protein overexpressing small-cell lung cancer cells. Eur J Phar-
macol 421: 1-9.
299. Renes J, de Vries EG, Nienhuis EF, Jansen PL, M uller M. 1999. ATP- and glutathione-
dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.
Br J Pharmacol 126: 681-688.
300. Chuman Y, Chen ZS, Seto K, Sumizawa T, Furukawa T, Tani A, Haraguchi M, Niwa K,
Yamada K, Aikou T, Akiyama S. 1998. Reversal of MRP-mediated vincristine resistance
in KB cells by buthionine sulfoximine in combination with PAK-104P. Cancer Lett 129:
69-76.
301. Rappa G, Lorico A, Flavell RA, Sartorelli AC. 1997. Evidence that the multidrug re-
sistance protein (MRP) functions as a co-transporter of glutathione and natural product
toxins. Cancer Res 57: 5232-5237.
302. Rappa G, Gamcsik MP, Mitina RL, Baum C, Fodstad O, Lorico A. 2003. Retroviral
transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity
to L-buthionine-
S
,
R
-sulphoximine (BSO): new rationale for the use of BSO in cancer
therapy. Eur J Cancer 39: 120-128.
303. Zaman GJ, Lankelma J, van Tellingen O, Beijnen JH, Dekker H, Paulusma C, Oude
Elferink RPJ, Baas F, Borst P. 1995. Role of glutathione in the export of compounds
from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA92:
7690-7694.
304. Salerno M, Petroutsa M, Garnier-Suillerot A. 2002. The MRP1-mediated effluxes of ar-
senic and antimony do not require arsenic-glutathione and antimony-glutathione complex
formation. J Bioenerg Biomembr 34: 135-145.
Search WWH ::
Custom Search